Consolidated Statements of Changes in Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect Period of Adoption Adjustment [Member]	Common Stock [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Retained Earnings [Member]	Retained Earnings [Member] Cumulative Effect Period of Adoption Adjustment [Member]
Beginning Balance at Feb. 02, 2019	$ 400,456	$ (6,276)	$ 153,066	$ (9,224)	$ 256,614	$ (6,276)
Beginning Balance, shares at Feb. 02, 2019			25,521
Net income	66,881				$ 66,881
Other comprehensive income (loss), net	(3,367)			(3,367)
Issuance and exercise of stock-based awards	2,010		$ 2,010
Issuance and exercise of stock-based awards, shares			307
Stock-based compensation expense	$ 6,382		$ 6,382
Accounting Standards Update [Extensible Enumeration]	us-gaap:AccountingStandardsUpdate201602Member				us-gaap:AccountingStandardsUpdate201602Member
Ending Balance at Feb. 01, 2020	$ 466,086		$ 161,458	(12,591)	$ 317,219
Ending Balance, shares at Feb. 01, 2020			25,828
Net income	76,227				76,227
Other comprehensive income (loss), net	13,530			13,530
Issuance and exercise of stock-based awards	3,722		$ 3,722
Issuance and exercise of stock-based awards, shares			465
Stock-based compensation expense	6,448		$ 6,448
Repurchase of common stock	(13,417)				(13,417)
Repurchase of common stock, shares			(694)
Ending Balance at Jan. 30, 2021	$ 552,596		$ 171,628	939	380,029
Ending Balance, shares at Jan. 30, 2021	25,599		25,599
Net income	$ 119,289				119,289
Other comprehensive income (loss), net	(14,402)			(14,402)
Issuance and exercise of stock-based awards	2,380		$ 2,380
Issuance and exercise of stock-based awards, shares			197
Stock-based compensation expense	6,816		$ 6,816
Repurchase of common stock	$ (198,361)				(198,361)
Repurchase of common stock, shares	(4,581)		(4,581)
Ending Balance at Jan. 29, 2022	$ 468,318		$ 180,824	$ (13,463)	$ 300,957
Ending Balance, shares at Jan. 29, 2022	21,215		21,215